BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

528 related articles for article (PubMed ID: 7723794)

  • 41. Codon 877 mutation in the androgen receptor gene in advanced prostate cancer: relation to antiandrogen withdrawal syndrome.
    Suzuki H; Akakura K; Komiya A; Aida S; Akimoto S; Shimazaki J
    Prostate; 1996 Sep; 29(3):153-8. PubMed ID: 8827083
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Mutated human androgen receptor gene detected in a prostatic cancer patient is also activated by estradiol.
    Elo JP; Kvist L; Leinonen K; Isomaa V; Henttu P; Lukkarinen O; Vihko P
    J Clin Endocrinol Metab; 1995 Dec; 80(12):3494-500. PubMed ID: 8530589
    [TBL] [Abstract][Full Text] [Related]  

  • 43. A gene transcription signature associated with hormone independence in a subset of both breast and prostate cancers.
    Creighton CJ
    BMC Genomics; 2007 Jun; 8():199. PubMed ID: 17598908
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The androgen receptor in prostate cancer.
    Trapman J; Brinkmann AO
    Pathol Res Pract; 1996 Jul; 192(7):752-60. PubMed ID: 8880876
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [Androgen receptor mutation and progression of prostate cancer].
    Ma JG; Li WP; Jiang YQ
    Zhonghua Nan Ke Xue; 2011 Jul; 17(7):649-54. PubMed ID: 21823352
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Androgen receptor gene mutations in human prostate cancer.
    Suzuki H; Sato N; Watabe Y; Masai M; Seino S; Shimazaki J
    J Steroid Biochem Mol Biol; 1993 Dec; 46(6):759-65. PubMed ID: 8274409
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Androgen receptor gene mutations in prostate cancer].
    Wang C; Uchida T
    Nihon Hinyokika Gakkai Zasshi; 1997 May; 88(5):550-6. PubMed ID: 9184448
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mutated androgen receptors of prostate-cancer cells.
    Figg WD; Middleman M; Sartor O
    N Engl J Med; 1995 Oct; 333(15):1010-1. PubMed ID: 7666906
    [No Abstract]   [Full Text] [Related]  

  • 49. Constitutive activation of the androgen receptor by a point mutation in the hinge region: a new mechanism for androgen-independent growth in prostate cancer.
    Céraline J; Cruchant MD; Erdmann E; Erbs P; Kurtz JE; Duclos B; Jacqmin D; Chopin D; Bergerat JP
    Int J Cancer; 2004 Jan; 108(1):152-7. PubMed ID: 14618630
    [TBL] [Abstract][Full Text] [Related]  

  • 50. The promiscuous receptor. Prostate cancer comes of age.
    Wilson JD
    N Engl J Med; 1995 May; 332(21):1440-1. PubMed ID: 7723802
    [No Abstract]   [Full Text] [Related]  

  • 51. Androgen receptor expression in prostate carcinoma cells suppresses alpha6beta4 integrin-mediated invasive phenotype.
    Bonaccorsi L; Carloni V; Muratori M; Salvadori A; Giannini A; Carini M; Serio M; Forti G; Baldi E
    Endocrinology; 2000 Sep; 141(9):3172-82. PubMed ID: 10965888
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Expression and somatic mutation on androgen receptor gene in prostate cancer.
    Segawa N; Nakamura M; Shan L; Utsunomiya H; Nakamura Y; Mori I; Katsuoka Y; Kakudo K
    Int J Urol; 2002 Oct; 9(10):545-53. PubMed ID: 12445232
    [TBL] [Abstract][Full Text] [Related]  

  • 53. DNA sequence of the androgen receptor in prostatic tumor cell lines and tissue specimens assessed by means of the polymerase chain reaction.
    Culig Z; Klocker H; Eberle J; Kaspar F; Hobisch A; Cronauer MV; Bartsch G
    Prostate; 1993; 22(1):11-22. PubMed ID: 8426836
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Androgens, antiandrogens and androgen receptor abnormalities.
    Kuil CW; Brinkmann AO
    Eur Urol; 1996; 29 Suppl 2():78-82. PubMed ID: 8717468
    [TBL] [Abstract][Full Text] [Related]  

  • 55. A splicing variant of the androgen receptor detected in a metastatic prostate cancer exhibits exclusively cytoplasmic actions.
    Jagla M; Fève M; Kessler P; Lapouge G; Erdmann E; Serra S; Bergerat JP; Céraline J
    Endocrinology; 2007 Sep; 148(9):4334-43. PubMed ID: 17540719
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Androgen receptor gene mutations in prostate cancer. Implications for disease progression and therapy.
    Culig Z; Hobisch A; Hittmair A; Cronauer MV; Radmayr C; Bartsch G; Klocker H
    Drugs Aging; 1997 Jan; 10(1):50-8. PubMed ID: 9111707
    [TBL] [Abstract][Full Text] [Related]  

  • 57. No evidence of FGFR3 mutations in prostate cancer.
    Zuiverloon TC; Boormans JL; Trapman J; van Leenders GJ; Zwarthoff EC
    Prostate; 2011 May; 71(6):637-41. PubMed ID: 20957671
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Androgen receptor gene mutations in human prostate cancer.
    Newmark JR; Hardy DO; Tonb DC; Carter BS; Epstein JI; Isaacs WB; Brown TR; Barrack ER
    Proc Natl Acad Sci U S A; 1992 Jul; 89(14):6319-23. PubMed ID: 1631125
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The role of androgen receptor gene mutations in male breast carcinoma.
    Hiort O; Naber SP; Lehners A; Muletta-Feurer S; Sinnecker GH; Zöllner A; Komminoth P
    J Clin Endocrinol Metab; 1996 Sep; 81(9):3404-7. PubMed ID: 8784104
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The androgen receptor: functional structure and expression in transplanted human prostate tumors and prostate tumor cell lines.
    Trapman J; Ris-Stalpers C; van der Korput JA; Kuiper GG; Faber PW; Romijn JC; Mulder E; Brinkmann AO
    J Steroid Biochem Mol Biol; 1990 Dec; 37(6):837-42. PubMed ID: 2285596
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.